pre-seed
Stage
About
Kovina is a preclinical stage biotechnology company developing first-in-class small molecule antiviral therapeutics targeting the HPV E6 oncogene to kill HPV-infected cells and treat HPV-driven cancers and premalignant infections.
Explore Kovina's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.